Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and Denali Therapeutics Inc. (DNLI)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and DNLI | ||
|---|---|---|
| S&P 500 | DNLI | |
| Start Date | Jan-01-2018 | Jan-31-2018 |
| Start Price | $2,543.70 | $23.26 |
| End Date | Oct-01-2024 | Oct-15-2024 |
| End Price | $5,708.75 | $26.85 |
| Number Monthly Prices | 82 | 82 |
| Min Date | Dec-01-2018 | Jul-31-2018 |
| Min Price | $3,185.80 | $12.59 |
| Max Date | Oct-01-2024 | Dec-31-2020 |
| Max Price | $5,708.75 | $83.76 |
| Total Return | 62.69% | 15.43% |
| Annualized Return | 7.38% | 2.12% |
| Current Value of $1,000 Purchase | $1,627 | $1,154 |
| Number Returns | 3,321 | 3,321 |
| Average Return | 18.12% | 30.92% |
| Minimum Return | -25.54% | -81.57% |
| Maximum Return | 79.19% | 565.29% |
| Number Profitable Returns | 2,737 | 1,859 |
| Percent Profitable Returns | 82.41% | 55.98% |
| Number Unprofitable Returns | 584 | 1,462 |
| Percent Unprofitable Returns | 17.59% | 44.02% |
| Profitable to Unprofitable Returns Ratio | 4.69 | 1.27 |
DNLI Performance Table and Chart
DNLI Dollar-cost Average
DNLI Trendline Chart
DNLI Moving Average Chart
DNLI Stock Return Map - See Patterns of Gains and Losses
DNLI Stock Returns/Purchase Dates